The Contribution of Prothrombotic Disorders to Peri- and Neonatal Ischemic Stroke

Meredith R. Golomb

doi:10.1055/s-2003-42591

Seminars in Thrombosis and Hemostasis, Inhaltsverzeichnis

Semin Thromb Hemost 2003; 29(4): 415-424
DOI: 10.1055/s-2003-42591

The Contribution of Prothrombotic Disorders to Peri- and Neonatal Ischemic Stroke

Meredith R. Golomb

Assistant Professor Division of Pediatric Neurology Department of Neurology Riley Hospital for Children Indiana University School of Medicine Indianapolis, Indiana

Abstract

ABSTRACT

Prothrombotic disorders are believed to be important contributors to the etiology of peri- and neonatal arterial ischemic stroke and sinovenous thrombosis, which may lead to life-long disability. This article reviews hematological issues unique to the perinatal period, including: the significance of the placenta as the interface between maternal and fetal circulations; normal changes in the coagulation system of mothers during and just after gestation; and the significance of prothrombotic disorders in the mother and/or fetus. Other possible maternal and neonatal contributors to peri- and neonatal stroke are discussed, including: infection, pre-eclampsia, diabetes, and drug use in the mother; and infection, dehydration, complex congenital heart disease, extracorporeal membrane oxygenation, and catheter placement in the neonate. Possible approaches to preventing and treating perinatal and neonatal stroke are presented.

KEYWORDS

Arterial ischemic stroke - sinovenous thrombosis - cerebrovascular accident - neonatal stroke - perinatal stroke - pregnancy - puerperium - placenta - prothrombotic disorder - coagulation

Volltext

Referenzen

REFERENCES

1 Humphreys P, Whiting S, Pham B. Hemiparetic cerebral palsy: clinical pattern and imaging in prediction of outcome. Can J Neurol Sci . 2000; 27 210-219
2 Uvebrant P. Hemiplegic cerebral palsy. Aetiology and outcome. Acta Paediatr Suppl 1988 345: 1-100
2a Friel J P. Dorland's Illustrated Medical Dictionary; 26th ed. Philadelphia: WB Saunders 1981
3 Schoenberg B S, Mellinger J F, Schoenberg D G. Cerebrovascular disease in infants and children: a study of incidence, clinical features, and survival. Neurology . 1978; 28 763-768
4 Broderick J, Talbot G T, Prenger E, Leach A, Brott T. Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage. J Child Neurol . 1993; 8 250-255
5 Giroud M, Lemesle M, Gouyon J B, Nivelon J L, Milan C, Dumas R. Cerebrovascular disease in children under 16 years of age in the city of Dijon, France: a study of incidence and clinical features from 1985 to 1993. J Clin Epidemiol . 1995; 48 1343-1348
6 deVeber G. Stroke and the child's brain: an overview of epidemiology, syndromes and risk factors. Curr Opin Neurol . 2002; 15 133-138
7 Gunther G, Junker R, Strater R. et al . Symptomatic ischemic stroke in full-term neonates: role of acquired and genetic prothrombotic risk factors [erratum appears in Stroke 2001;32:279]. Stroke . 2000; 31 2437-4241
8 deVeber G, Group CPISS. Canadian Paediatric Ischemic Stroke Registry: analysis of children with arterial ischemic stroke [abstract]. Ann Neurol . 2000; 48 526
9 Monagle P, deVeber G, Chan K C, Andrew M. Thromboembolic disease and antithrombotic therapy in newborns. Blood; 43rd annual meeting of the American Society of Hematology (syllabus), December 7-11, 2001, Orlando, Florida
10 Estan J, Hope P. Unilateral neonatal infarction in full term neonates. Arch Dis Child . 1997; 76 F88-93
11 Lynch J, Nelson K B. Neonatal stroke in the United States: results of the national hospital discharge survey, 1980-1998 (Abst). Neurology . 2001; 56 A10
12 Golomb M, MacGregor D, Domi T. et al . Presumed pre- and perinatal stroke: risk factors and outcomes. Ann Neurol . 2001; 50 163-168
13 deVeber G, Andrew M, Group CPSS. The epidemiology and outcome of sinovenous thrombosis in pediatric patients. N Engl J Med . 2001; 345 417-423
14 Sadler T. Langman's Medical Embryology. Baltimore, MD: Williams & Wilkins 1990: 411
15 Andrew M, Monagle P, Brooker L. Thromboembolic Complications during Infancy and Childhood. Hamilton, Ontario: BC Decker 2000
16 Redline R W, Wilson-Costello D, Borawski E, Fanaroff A A, Hack M. Placental lesions associated with neurologic impairment and cerebral palsy in very-low-birth-weight infants. Arch Pathol Lab Med . 1998; 122 1091-1098
17 Burke C J, Tannenberg A E. Prenatal brain damage and placental infarction-an autopsy study. Dev Med Child Neurol . 1995; 37 555-562
18 Kraus F T, Acheen V I. Fetal thrombotic vasculopathy in the placenta: cerebral thrombi and infarcts, coagulopathies, and cerebral palsy. Hum Pathol . 1999; 30 759-769
19 Amato M, Huppi P, Herschkowitz N, Huber P. Prenatal stroke suggested by intrauterine ultrasound and confirmed by magnetic resonance imaging. Neuropediatrics . 1991; 22 100-102
20 Adams-Chapman I, Vaucher Y E, Bejar R F, Benirschke K, Baergen R N, Moore T R. Maternal floor infarction of the placenta: association with central nervous system injury and adverse neurodevelopmental outcome. J Perinatol . 2002; 22 236-241
21 Viscardi R M, Sun C C. Placental lesion multiplicity: risk factor for IUGR and neonatal cranial ultrasound abnormalities. Early Hum Dev . 2001; 62 1-10
22 Grafe M R. The correlation of prenatal brain damage with placental pathology. J Neuropathol Exp Neurol . 1994; 53 407-415
23 Clark P, Greer I A, Walker I D. Interaction of the protein C/protein S anticoagulant system, the endothelium and pregnancy. Blood Rev . 1999; 13 127-146
24 Aune B, Gjesdal K, Oian P. Late onset postpartum thrombocytosis in pre-eclampsia. Acta Obstet Gynecol Scand . 1999; 78 866-870
25 Atalla R K, Thompson J R, Oppenheimer C A, Bell S C, Taylor D J. Reactive thrombocytosis after caesarean section and vaginal delivery: implications for maternal thromboembolism and its prevention. Br J Obstet Gynaecol . 2000; 107 411-414
26 Kittner S J, Stern B J, Feeser B R. et al . Pregnancy and the risk of stroke. N Engl J Med . 1996; 335 768-774
27 Jaigobin C, Silver F L. Stroke and pregnancy. Stroke . 2000; 31 2948-2951
28 Skidmore F M, Williams L S, Fradkin K D, Alonso R J, Biller J. Presentation, etiology, and outcome of stroke in pregnancy and puerperium. J Stroke Cerebrovasc Dis . 2001; 10 1-10
29 Lanska D J, Kryscio R J. Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Stroke . 2000; 31 1274-1282
30 Sharshar T, Lamy C, Mas J L. Incidence and causes of strokes associated with pregnancy and puerperium. A study in public hospitals of Ile de France. Stroke in Pregnancy Study Group. Stroke . 1995; 26 930-936
31 Hallak M, Senderowicz J, Cassel A. et al . Activated protein C resistance (factor V Leiden) associated with thrombosis in pregnancy. Am J Obstet Gynecol . 1997; 176 889-893
32 Tollin S R, Seely E W. Case report: postpartum hypopituitarism in a patient with sickle cell trait. Am J Med Sci . 1994; 308 35-37
33 van Pampus G M, Dekker G A, Wolf H. et al . High prevalence of hemostatic abnormalities in women with a history of severe pre-eclampsia. Am J Obstet Gynecol . 1999; 180 1146-1150
34 van Pampus G M, van den Ende A, Wolf H. Elevated levels of lipoprotein(a) in women with pre-eclampsia. Am J Obstet Gynecol . 1998; 179 1103-1104
35 Dzialo A F, Black-Schaffer R M. Cerebral venous thrombosis in young adults: 2 Case reports. Arch Phys Med Rehabil . 2001; 82 683-688
36 Gokcil Z, Odabasi Z, Vural O, Yardim M. Cerebral venous thrombosis in pregnancy: the role of protein S deficiency. Acta Neurol Belg . 1998; 98 36-38
37 Ozsener S, Terek M C, Saydam G, Celebisoy N, Oztekin K, Ozkinay E. Intracranial venous thrombosis associated with severe antithrombin-III deficiency in pregnancy. J Obstet Gynaecol Res . 2001; 27 81-84
38 Bansal B C, Gupta R R, Prakash C. Stroke during pregnancy and puerperium in young females below the age of 40 years as a result of cerebral venous/venous sinus thrombosis. Jpn Heart J . 1980; 21 171-183
39 Ballem P. Acquired thrombophilia in pregnancy. Semin Thromb Hemost . 1998; 24(Suppl 1) 41-47
40 Ogasawara M, Sasa H, Kajiura S, Aoki K, Yagami Y. Successful management of congenital protein C deficiency with recurrent pregnancy loss. Int J Gynaecol Obstet . 1995; 50 185-187
41 Alonso A, Soto I, Urgelles M F, Corte J R, Rodriguez M J, Pinto C R. Acquired and inherited thrombophilia in women with unexplained fetal losses. Am J Obstet Gynecol . 2002; 187 1337-1342
42 Katz V L, DiTomasso J, Farmer R, Carpenter M. Activated protein C resistance associated with maternal floor infarction treated with low-molecular-weight heparin. Am J Perinatol . 2002; 19 273-277
43 Thorarensen O, Ryan S, Hunter J, Younkin D P. Factor V Leiden mutation: an unrecognized cause of hemiplegic cerebral palsy, neonatal stroke, and placental thrombosis [comments]. Ann Neurol . 1997; 42 372-375
44 Khong T Y, Hague W M. The placenta in maternal hyperhomocysteinaemia. Br J Obstet Gynaecol . 1999; 106 273-278
45 Magid M S, Kaplan C, Sammaritano L R, Peterson M, Druzin M L, Lockshin M D. Placental pathology in systemic lupus erythematosus: a prospective study. Am J Obstet Gynecol . 1998; 179 226-234
46 Anyaegbunam A, Mikhail M, Axioitis C, Morel M I, Merkatz I R. Placental histology and placental/fetal weight ratios in pregnant women with sickle cell disease: relationship to pregnancy outcome. J Assoc Acad Minor Phys . 1994; 5 123-125
47 Becroft D M, Thompson J M, Mitchell E A. The epidemiology of placental infarction at term. Placenta . 2002; 23 343-351
48 Naeye R L. Placental infarction leading to fetal or neonatal death. A prospective study. Obstet Gynecol . 1977; 50 583-588
49 Schjetlein R, Abdelnoor M, Haugen G, Husby H, Sandset P M, Wisloff F. Hemostatic variables as independent predictors for fetal growth retardation in pre-eclampsia. Acta Obstet Gynecol Scand . 1999; 78 191-197
50 Weenink G H, Treffers P E, Vijn P, Smorenberg-Schoorl M E, ten Cate W J. Antithrombin III levels in pre-eclampsia correlate with maternal and fetal morbidity. Am J Obstet Gynecol . 1984; 148 1092-1097
51 Bendon R W, Bornstein S, Faye-Petersen O M. Two fetal deaths associated with maternal sepsis and with thrombosis of the intervillous space of the placenta. Placenta . 1998; 19 385-389
52 Naeye R L. The outcome of diabetic pregnancies: a prospective study. Ciba Found Symp . 1978; 227-241
53 Grether J K, Nelson K B. Maternal infection and cerebral palsy in infants of normal birth weight [comments] [erratum published in JAMA 1998;279:118]. JAMA . 1997; 278 207-211
54 Grether J K, Nelson K B, Emery 3rd S E, Cummins S K. Prenatal and perinatal factors and cerebral palsy in very-low-birth-weight infants [comments]. J Pediatr . 1996; 128 407-414
55 Beebe L A, Cowan L D, Altshuler G. The epidemiology of placental features: associations with gestational age and neonatal outcome. Obstet Gynecol . 1996; 87 771-778
56 Slutsker L. Risks associated with cocaine use during pregnancy. Obstet Gynecol . 1992; 79 778-789
57 Burstein Y, Giardina P J, Rausen A R, Kandall S R, Siljestrom K, Peterson C M. Thrombocytosis and increased circulating platelet aggregates in newborn infants of polydrug users. J Pediatr . 1979; 94 895-899
58 Amit M, Camfield P R. Neonatal polycythemia causing multiple cerebral infarcts. Arch Neurol . 1980; 37 109-110
59 Clancy R, Malin S, Laraque D, Baumgart S, Younkin D. Focal motor seizures heralding stroke in full-term neonates. Am J Dis Child . 1985; 139 601-606
60 Govaert P, Achten E, Vanhaesebrouck P, De Praeter C, Van Damme J. Deep cerebral venous thrombosis in thalamo-ventricular hemorrhage of the term newborn. Pediatr Radiol . 1992; 22 123-127
61 Konishi Y, Kuriyama M, Sudo M, Konishi K, Hayakawa K, Ishii Y. Superior sagittal sinus thrombosis in neonates. Pediatr Neurol . 1987; 3 222-225
62 Andrew M, Paes B, Milner R. et al . Development of the human coagulation system in the full-term infant. Blood . 1987; 70 165-172
63 Andrew M. Developmental hemostasis: relevance to hemostatic problems during childhood. Semin Thromb Hemost . 1995; 21 341-356
64 deVeber G, Monagle P, Chan A. et al . Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch Neurol . 1998; 55 1539-1543
65 Powars D R, Weiss J N, Chan L S, Schroeder W A. Is there a threshold level of fetal hemoglobin that ameliorates morbidity in sickle cell anemia?. Blood . 1984; 63 921-926
66 Golomb M R. Sinovenous thrombosis in neonates. Semin Cerebrovasc Dis Stroke . 2001; 1 216-224
67 Riela A R, Roach E S. Etiology of stroke in children. J Child Neurol . 1993; 8 201-220
68 Terplan K L. Brain changes in newborns, infants and children with congenital heart disease in association with cardiac surgery. Additional observations. J Neurol . 1976; 212 225-236
69 Lynch J K, Nelson K B. Epidemiology of perinatal stroke. Curr Opin Pediatr . 2001; 13 499-505
70 Kuharik M A, Edwards M K. Cerebral venous distention associated with cardiac failure in infants. AJNR Am J Neuroradiol . 1987; 8 657-659
71 Wu Y W, Miller S P, Chin K. et al . Multiple risk factors in neonatal sinovenous thrombosis. Neurology . 2002; 59 438-440
72 Strater R, Vielhaber H, Kassenbohmer R, von Kries R, Göbel U, Nowak-Göttl U. Genetic risk factors of thrombophilia in ischaemic childhood stroke of cardiac origin. A prospective ESPED survey. Eur J Pediatr . 1999; 158(Suppl 3) S122-125
73 Petäjä J, Peltola K, Sairanen H. et al . Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations. J Thorac Cardiovasc Surg . 1996; 112 665-671
74 Zwischenberger J B, Nguyen T T, Upp Jr R J. et al . Complications of neonatal extracorporeal membrane oxygenation. Collective experience from the Extracorporeal Life Support Organization. J Thorac Cardiovasc Surg . 1994; 107 838-849
75 Bernbaum J, Schwartz I P, Gerdes M, D'Agostino J A, Coburn C E, Polin R A. Survivors of extracorporeal membrane oxygenation at 1 year of age: the relationship of primary diagnosis with health and neurodevelopmental sequelae. Pediatrics . 1995; 96 907-913
76 Taylor G A, Fitz C R, Kapur S, Short B L. Cerebrovascular accidents in neonates treated with extracorporeal membrane oxygenation: sonographic-pathologic correlation. AJR Am J Roentgenol . 1989; 153 355-361
77 Jarjour I T, Ahdab-Barmada M. Cerebrovascular lesions in infants and children dying after extracorporeal membrane oxygenation. Pediatr Neurol . 1994; 10 13-19
78 Muntean W. Coagulation and anticoagulation in extracorporeal membrane oxygenation. Artif Organs . 1999; 23 979-983
79 Andrew M. The relevance of developmental hemostasis to hemorrhagic disorders of newborns. Semin Perinatol . 1997; 21 70-85
80 Barmada M A, Moossy J, Shuman R M. Cerebral infarcts with arterial occlusion in neonates. Ann Neurol . 1979; 6 495-502
81 Roach E S. Stroke in children. Curr Treat Options Neurol . 2000; 2 295-304
82 Ment L R, Ehrenkranz R A, Duncan C C. Bacterial meningitis as an etiology of perinatal cerebral infarction. Pediatr Neurol . 1986; 2 276-279
83 Nowak-Göttl U, von Kries R, Göbel U. Neonatal symptomatic thromboembolism in Germany: two year survey [comments]. Arch Dis Child Fetal Neonatal Ed . 1997; 76 F163-167
84 Fritsch G. Acute infantile hemiplegia caused by cerebral ischemic infarction. Etiology, clinical features and investigations. Pädiatrie Pädologie . 1984; 19 287-301
85 Gebara B M, Everett K O. Dural sinus thrombosis complicating hypernatremic dehydration in a breastfed neonate. Clin Pediatr . 2001; 40 45-48
86 Barron T F, Gusnard D A, Zimmerman R A, Clancy R R. Cerebral venous thrombosis in neonates and children. Pediatr Neurol . 1992; 8 112-116
87 Vailas G N, Brouillette R T, Scott J P, Shkolnik A, Conway J, Wiringa K. Neonatal aortic thrombosis: recent experience. J Pediatr . 1986; 109 101-108
88 Lemke R P, Idiong N, al-Saedi S. et al . Spinal cord infarct after arterial switch associated with an umbilical artery catheter. Ann Thorac Surg . 1996; 62 1532-1534
89 Ruff R L, Shaw C M, Beckwith J B, Iozzo R V. Cerebral infarction complicating umbilical vein catheterization. Ann Neurol . 1979; 6 85
90 Reinecke H, Nabavi D G, Allroggen A, Droste D W, Breithardt G, Ringelstein E B. Detection of circulating cerebral microemboli by transcranial Doppler ultrasonography [in German]. Z Kardiol . 2001; 90 43-51
91 Newton T H, Gooding C A. Compression of superior sagittal sinus by neonatal calvarial molding. Radiology . 1975; 115 635-640
92 Cowan F, Thoresen M. Changes in superior sagittal sinus blood velocities due to postural alterations and pressure on the head of the newborn infant. Pediatrics . 1985; 75 1038-1047
93 Earley C J, Kittner S J, Feeser B R. et al . Stroke in children and sickle-cell disease: Baltimore-Washington Cooperative Young Stroke Study. Neurology . 1998; 51 169-176
94 Strater R, Becker S, von Eckardstein A. et al . Prospective assessment of risk factors for recurrent stroke during childhood-a 5-year follow-up study. Lancet . 2002; 360 1540-1545
95 Golomb M. Walking after neonatal arterial ischemic stroke and sinovenous thrombosis: predictors of probability of walking over time and parental perception of gait [master's thesis]. Toronto: University of Toronto 2002
96 Lanthier S, Carmant L, David M, Larbrisseau A, de Veber G. Stroke in children: the coexistence of multiple risk factors predicts poor outcome. Neurology . 2000; 54 371-378
97 Sun P M, Wilburn W, Raynor B D, Jamieson D. Sickle cell disease in pregnancy: twenty years of experience at Grady Memorial Hospital, Atlanta, Georgia. Am J Obstet Gynecol . 2001; 184 1127-1130
98 Rahimy M C, Gangbo A, Adjou R, Deguenon C, Goussanou S, Alihonou E. Effect of active prenatal management on pregnancy outcome in sickle cell disease in an African setting. Blood . 2000; 96 1685-1689
99 Kutteh W H, Ermel L D. A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin. Am J Reprod Immunol . 1996; 35 402-407
100 Pattison N S, Chamley L W, Birdsall M, Zanderigo A M, Liddell H S, McDougall J. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome?. <~>A randomized controlled trial. Am J Obstet Gynecol . 2000; 183 1008-1012
101 Sher G, Matzner W, Feinman M. et al . The selective use of heparin/aspirin therapy, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody-positive women undergoing in vitro fertilization. Am J Reprod Immunol . 1998; 40 74-82
102 Buchanan N M, Khamashta M A, Morton K E, Kerslake S, Baguley E A, Hughes G R. A study of 100 high-risk lupus pregnancies. Am J Reprod Immunol . 1992; 28 192-194
103 Diejomaoh M F, Al-Azemi M M, Bandar A. et al . A favorable outcome of pregnancies in women with primary and secondary recurrent pregnancy loss associated with antiphospholipid syndrome. Arch Gynecol Obstet . 2002; 266 61-66
104 Farquharson R G, Quenby S, Greaves M. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol . 2002; 100 408-413
105 Branch D W, Peaceman A M, Druzin M. et al . A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. Am J Obstet Gynecol . 2000; 182 122-127
106 Sherer Y, Levy Y, Shoenfeld Y. Intravenous immunoglobulin therapy of antiphospholipid syndrome. Rheumatology (Oxford) . 2000; 39 421-426
107 Many A, Pauzner R, Carp H, Langevitz P, Martinowitz U. Treatment of patients with antiphospholipid antibodies during pregnancy. Am J Reprod Immunol . 1992; 28 216-218
108 Walker I D. Thrombophilia in pregnancy. J Clin Pathol . 2000; 53 573-580
109 Andrew M, Brooker L, Leaker M, Paes B, Weitz J. Fibrin clot lysis by thrombolytic agents is impaired in newborns due to a low plasminogen concentration. Thromb Haemost . 1992; 68 325-330
110 Massicotte P, Adams M, Marzinotto V, Brooker L A, Andrew M. Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study. J Pediatr . 1996; 128 313-318
111 deVeber G, Chan A, Monagle P. et al . Anticoagulation therapy in pediatric patients with sinovenous thrombosis: a cohort study. Arch Neurol . 1998; 55 1533-1537
112 Ettingshausen C E, Veldmann A, Beeg T, Schneider W, Jäger G, Kreuz W. Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans. Semin Thromb Hemost . 1999; 25 537-541
113 Dreyfus M, Masterson M, David M. et al . Replacement therapy with a monoclonal antibody purified protein C concentrate in newborns with severe congenital protein C deficiency. Semin Thromb Hemost . 1995; 21 371-381
114 Kreuz W D, Schneider W, Nowak-Göttl U. Treatment of consumption coagulopathy with antithrombin concentrate in children with acquired antithrombin deficiency-a feasibility pilot study. Eur J Pediatr . 1999; 158(Suppl 3) S187-191
115 Hossmann V, Heiss W D, Bewermeyer H. Antithrombin III deficiency in ischaemic stroke. Klin Wochenschr . 1983; 61 617-620
116 Ueyama H, Hashimoto Y, Uchino M. et al . Progressing ischemic stroke in a homozygote with variant antithrombin III. Stroke . 1989; 20 815-818
117 de Jonge E, van der Poll T, Kesecioglu J, Levi M. Anticoagulant factor concentrates in disseminated intravascular coagulation: rationale for use and clinical experience. Semin Thromb Hemost . 2001; 27 667-674
118 Kahn M J, Scher C, Rozans M, Michaels R K, Leissinger C, Krause J. Factor V Leiden is not responsible for stroke in patients with sickling disorders and is uncommon in African Americans with sickle cell disease. Am J Hematol . 1997; 54 12-5
119 Mader I, Schoning M, Klose U, Kuker W. Neonatal cerebral infarction diagnosed by diffusion-weighted MRI: pseudonormalization occurs early. Stroke . 2002; 33 1142-1145